Showing results (451-460 of 4,698) with videos related to
Sort By:
Pageof 470
Seminars in Oncology|October 13, 1998
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapyP Lemez, J MaresováSeminars in Oncology|October 13, 1998
Antineoplastic activity of continuous exposure to dexrazoxane: potential new role as a novel topoisomerase II inhibitorT W Synold, M L Tetef, J H DoroshowSeminars in Oncology|October 24, 1998
Therapeutic options for the treatment of colorectal cancer following 5-fluorouracil failureC A HendersonSeminars in Oncology|August 1, 1996
The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancerJ F Simpson, D L PageSeminars in Oncology|August 1, 1996
Primary chemotherapy in operable breast cancerG Bonadonna, P ValagussaSeminars in Oncology|April 1, 1993
Advances in surgical staging and therapy of non-small-cell lung cancerD J Sugarbaker, G M StraussSeminars in Oncology|February 14, 2002
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasoneAndreas H Sarris, Yunfang Jiang, Apostolia M Tsimberidou, et al.Seminars in Oncology|February 14, 2002
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K LinkSeminars in Oncology|February 14, 2002
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphomaLeo I Gordon, Thomas E Witzig, Greg A Wiseman, et al.Pageof 470